Vector-borne diseases (VBDs) pose a significant public health challenge in India, with a high burden of morbidity and mortality. This article provides a comprehensive overview of the prevalence and management of VBDs in the country, offering valuable insights for healthcare professionals.
India is endemic to several VBDs, including malaria, dengue, chikungunya, and Japanese encephalitis. The National Vector Borne Disease Control Programme (NVBDCP) reports that malaria alone accounts for 1.5 million cases annually. Dengue cases have also seen a sharp increase in recent years, with over 100,000 cases reported in 2017.
The management of VBDs in India is fraught with challenges. These include inadequate surveillance, lack of public awareness, and socio-economic factors. The vast geographical diversity of India also plays a role in the spread and control of these diseases.
The NVBDCP implements various strategies for controlling VBDs, including vector control, early case detection, and prompt treatment. The government has also launched the National Health Mission (NHM) to strengthen healthcare delivery at the grassroots level. Despite these efforts, the burden of VBDs remains high, necessitating more effective strategies.
Healthcare professionals play a critical role in managing VBDs. They are responsible for early diagnosis, appropriate treatment, and patient education. Their role also extends to community engagement, where they can contribute to disease prevention by raising awareness about vector control and personal protection.
Despite significant challenges, there is a growing recognition of the importance of managing VBDs in India. The role of healthcare professionals is pivotal in this endeavor. By fostering a better understanding of the prevalence and management of these diseases, this guide aims to equip healthcare professionals with the knowledge required to combat VBDs effectively.
1.
Researchers found that patients undergoing chemotherapy had a higher risk of mixed infections and should begin antibiotic therapy right away.
2.
Study confirms safety and efficacy of higher-dose-per-day radiation for early-stage prostate cancer
3.
Admissions, medical schools, costs, and eligibility requirements information for FNB Onco-Anesthesia.
4.
Radiation therapy can promote amphiregulin, which increases growth of metastases
5.
High Success Rate With Conversion Therapy for Unresectable Gastroesophageal Cancer
1.
Learning from Uncommon Inherited Bleeding Disorder Presentations
2.
Essential Strategies in Hematology for Healthcare Excellence
3.
An Overview Of Leukemia Cutis: What It Is And How To Treat It
4.
All About Ferric Gluconate – The Best Source Of Iron For Anemia
5.
Lymphomatoid Papulosis: What You Need to Know
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Beyond the Mutation: Addressing the Unmet Needs in ALK-Positive NSCLC
2.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part VI
3.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part IV
4.
Exploring Potentials of Lorlatinib: The Third Generation ALK-TKI Through CROWN Trial
5.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part I
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation